Clinical findings using echocardiography and plasma cardiac troponin I and pathological findings in dogs with hypertrophic cardiomyopathy: A retrospective study
Background: Hypertrophic cardiomyopathy (HCM) is considered rare in dogs, and there is a lack of clinical data. Cardiac troponin I (cTnI) is a biomarker of cardiomyocyte damage and necrosis and can be used to diagnose cat and human HCM. Aim: We investigated whether the presence of cTnI in clinical...
Main Authors: | Takeki Ando, Takeshi Izawa, Hidetaka Nishida, Hideo Akiyoshi |
---|---|
Format: | Article |
Language: | English |
Published: |
Tripoli University
2023-06-01
|
Series: | Open Veterinary Journal |
Subjects: | |
Online Access: | https://www.openveterinaryjournal.com/?mno=144798 |
Similar Items
-
Сlinical features of hypertrophic cardiomyopathy depending on the age of onset of clinical manifestations and the presence of cardiometabolic risk factors
by: V. G. Davydova, et al.
Published: (2023-05-01) -
Clinical and hemodynamic effects of carvedilol in patients with hypertrophic cardiomyopathy
by: T. A. Abdullaev, et al.
Published: (1970-01-01) -
Association of NT-proBNP and hs-cTnT with Imaging Markers of Diastolic Dysfunction and Focal Myocardial Fibrosis in Hypertrophic Cardiomyopathy
by: Céleste Chevalier, et al.
Published: (2022-08-01) -
Elevated high-sensitivity troponin T levels are associated with adverse cardiac remodelling and myocardial fibrosis in hypertrophic cardiomyopathy
by: Stefanie Hasler, et al.
Published: (2016-03-01) -
Clinical features of hypertrophic cardiomyopathy depending on the hereditary factor
by: V. G. Davydova, et al.
Published: (2023-08-01)